Effects of Candesartan on Cough and Bronchial Hyperresponsiveness in Mildly to Moderately Hypertensive Patients With Symptomatic Asthma | Zendy

Hiroshi Tanaka | Zendy; Shin Teramoto | Zendy; K Oashi | Zendy; Toyohiro Saikai | Zendy; Shintaro Tanaka | Zendy; Kazuhiko Suzuki | Zendy; Midori Hashimoto | Zendy; Shosaku Abe | Zendy

Open Access

Effects of Candesartan on Cough and Bronchial Hyperresponsiveness in Mildly to Moderately Hypertensive Patients With Symptomatic Asthma

Author(s) -

Hiroshi Tanaka,

Shin Teramoto,

K Oashi,

Toyohiro Saikai,

Shintaro Tanaka,

Kazuhiko Suzuki,

Midori Hashimoto,

Shosaku Abe

Publication year - 2001

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.104.3.281

Subject(s) - medicine , candesartan , bronchial hyperresponsiveness , asthma , cardiology , airway hyperresponsiveness , anesthesia , respiratory disease , blood pressure , angiotensin ii , lung

Candesartan, an AT(1) receptor antagonist, has been reported to have no association with persistent cough in subjects with hypertension, but there has been no study on the safety of its administration to hypertensive patients with symptomatic asthma. The aim of this study was to compare the adverse effects of candesartan and calcium antagonists on cough, pulmonary function, and bronchial hyperresponsiveness in these patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research